The Trinity – Balance of Safety, Efficacy, and Quality of Life in TCR RRMM treatment
Friday 16th May 2025 | 07:30–08:15 CEST
Chair and speakers
Chair: María Victoria Mateos, PhD, Associate Professor Director of the Myeloma Program at the University of Salamanca, Spain
Claudio Cerchione, PhD, Adjunct Professor at Department of Pharmacy and Biotechnology, University of Bologna, Italy
Manfred Welslau, Dr, PhD, Head of the Department of Oncology at Klinikum Aschaffenburg-Alzenau in Germany
| AGENDA |
|---|
| Current treatment challenges: Unmet need in a vulnerable patient group |
| Introducing a new way of evaluating treatment for MM patients: The Trinity |
| Pepaxti data insights for TCR RRMM: Safety, Efficacy and QoL |
| Panel discussion: Real-world patient cases |
MED-ALL—2500010 April 2025
